Levoximed (Eye/Aer Drops)

Each ml contains levofloxacin 5 mg.

- Treatment of superficial bacterial infections of eyes, caused by susceptible to levofloxacin microorganisms, in patients at the age from 1 year and older;
- Bacterial conjunctivitis;
- Purulent corneal ulcer;
- Gonorrheal and chlamydial diseases of eyes in adults;
- Prophylaxis of complications after surgical and laser operations in eye.
- Otitis externa;
- Acute and chronic otitis media;
- Prophylaxis of infectious otitis before and after surgery, at ear traumas, extraction of foreign body from external auditory meatus, accompanied by ear tissues damage.

- Hypersensitivity to levofloxacin and other drug components;
- Hypersensitivity to drugs of quinolone group.

In less than 3% of cases short time eye burning sense, visual acuity decrement, mucus appearance in the form of strands; in less than 1% of cases eyelids adhesion, chemosis, papillary conjunctivitis, eyelid edema, unpleasant sensation in eye: itching, pain, hyperaemia of conjunctiva, follicles appearance in conjunctiva, dry eye syndrome, eyelid erythema, lacnmation, photophobia.

Only for local use. Ophtalmology: Adults and children older than 1 year: during first 2 days 1-2 drops are instilled into one/both affected eyes every 2 hours till 8 times per day. During 3-7 days every 4 hours (up to 4 times per day). Treatment duration depends on the severity of disease and evolution of clinical and bacteriological infection. The duration of treatment usually makes 7 days. At concomitant application of several ophthalmologic drugs for local use it is necessary to keep the interval of 15 minutes between instillations. In order to avoid solution contamination, it is not allowed to touch with dropper tip to eyelids and tissues around the eye.
Otology: At otitis externa: Adults: 10 drops are instilled into effected ear 1 times per day during 7 days. Children from 1 year to 12 years old: 5 drops are instilled into effected ear 1 times per day during 7 days. At chronic suppurative otitis media (with perforation of tympanic membrane): patients at the age of 12 years and older 10 drops are instilled into effected ear 2 times per day during 14 days.
At prophylaxis of infectious otitis: 5 drops are instilled into effected ear 2 times per day during 10 days. The sanitization external acoustic meatus should be provided before drops Levoximed instillation into ear. The solution should be instilled into acoustic meatus. The patient lies down, making affected ear upwards and should stay in such position at least 5 minutes after drug instillation. The drops should flow down after instillation into acoustic meatus, pulling off earlap down and backwards. Cotton swab may be placed into acoustic neatus. It is recommended to warm the solution before instillation, holding it in hands for 1-2 minutes.

Due to the absence of data of clinical study concerning the administration of preparation during pregnancy, use of eye/ear drops of levofloxacin is possible if the expected benefit of therapy exceeds the potential risk. It is necessary to use Levoximed carefully during lactation period.

Eye/ear drops contain benzalkonium chloride as a preservative. The drug should not be applied during hydrophilic (soft) contact lenses wearing, as this preservative may be absorbed and cause eye irritation.

5 ml vial with dropping stopper and screw cap, supplied with guard ring. 1 vial in carton box with packaging leaflet.


Floximed (Eye Ointment)

Floximed (Eye/Ear Drops)

Fluzamed (Eye/Ear Drops)

Futaron (Eye Drops)

Levoximed (Eye/Ear Drops)

Tobrimed (Eye Drops)

Tobrimed (Eye Ointment)

 Events & Exhibitions


The most likely diagnosis is:

a. traction retinal detachment
b. tigroid fundus
c. epiretinal membrane
d. thyroid-related ophthalmopathy

WOC 2014 in Tokyo, Japan
Online submission of abstracts will open on March 1, 2013. The deadline for abstract submission is July 26, 2013 at midnight in Tokyo. Submissions will be reviewed by the WOC 2014 Scientific Program Committee. Primary authors will be notified of acceptance by early October, 2013.

Researchers Develop Gene Therapy That Could Correct A Common Form Of Blindness
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.

Oxygen Therapy Helps Heal Chemical and Thermal Burns in the Eyes
Scientists at the Department of Ophthalmology, Ahvaz Jundishapur University of Medical Sciences, treated 24 eyes of 22 patients with acute chemical and thermal burns in their eyes.

Glaucoma Causes Higher Risk of Falls Among Older Adults
Glaucoma can affect a person's downward field of view, and this seems to be causing a higher risk of falls resulting in injury among older people with the eye disease.

Why Do Birds Fly into Power Lines? Is Poor Vision the Problem?
esearch suggests that collision with human structures is the largest unintended human cause of bird deaths

Diabetes and Hypertension Increase Glaucoma Risk
People with diabetes and/or hypertension are more likely to develop open-angle glaucoma (OAG) as well.

Be Careful Out There: Fireworks Caused 1,300 Eye Injuries in One Month in 2010
Sparklers caused about 200 U.S. eye injuries during a one-month period in 2010.

High Visual Perception Ability in Autistic People Explained
It has been noticed before that autistic people are highly able to process visual information, and this may be why.

Why Cold Temperatures Increase Eye Dryness
In fact, the meibum can solidify in cold temperatures and block the meibomian gland ducts

Home      |      Site Map      |      Terms of Use      |      Privacy Policy

2012 World Medicine Ophthalmics. All Rights Reserved.